By Business/Source
Currency:USD
2025/FY
2025/FY
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/FY
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/FY
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/FY
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/FY
2021/Q4
2021/Q3
2021/Q2
2021/Q1
2020/FY
2020/Q3
2020/Q2
2019/FY
2018/FY
2017/FY
2016/FY
2015/FY
2015/Q4
2015/Q3
2015/Q2
2015/Q1
2014/FY
2014/Q4
2014/Q3
2014/Q2
2014/Q1
2013/FY
2013/Q4
2013/Q3
2013/Q2
2013/Q1
2012/FY
2012/Q4
2012/Q3
2012/Q2
2012/Q1
2011/FY
2011/Q4
2011/Q3
2011/Q2
2011/Q1
2010/FY
2010/Q4
2010/Q3
2010/Q2
2010/Q1
2009/FY
2009/Q4
2009/Q3
2009/Q2
2009/Q1
2008/FY
2008/Q4
2008/Q3
2008/Q2
2008/Q1
2007/FY
2007/Q4
2007/Q3
2007/Q2
2007/Q1
2006/FY
2006/Q4
2006/Q3
2006/Q2
2006/Q1
2005/FY
2005/Q4
2005/Q3
2005/Q2
2005/Q1
2004/FY
Stock NameRevenueRatio
Bruker Scientific Instruments (BSI) Chemicals, Applied Markets,Life Science,In Vitro Diagnostics,1.21B35.22%
Bruker Scientific Instrument (BSI) Nano1.08B31.55%
Bruker Scientific Instruments (BSI) BioSpin878.8M25.57%
Bruker Energy & Supercon Technologies (BEST)270.9M7.88%
Intersegment revenue-7.7M-0.22%
By Country/Region
Currency:USD
2025/FY
2025/FY
2024/FY
2023/FY
2022/FY
2021/FY
2020/FY
2019/FY
2018/FY
2017/FY
2016/FY
2015/FY
2014/FY
2013/FY
2012/FY
2011/FY
2010/FY
2009/FY
Stock NameRevenueRatio
Europe excluding Germany950.2M27.65%
United States891.3M25.94%
Asia Pacific excluding China552.6M16.08%
China475.8M13.85%
Germany297M8.64%
Other269.6M7.85%
View all